Pedram Afshar,Timothy J. Denison,David E. Linde,Scott R. Stanslaski
申请号：
US14599126
公开号：
US10016606B2
申请日:
2015.01.16
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The disclosure describes a method and system or controlling symptoms of patients suffering from Parkinson's Disease. In some examples, one or more biomarkers indicative of a patient's present symptoms are determined. The biomarkers may be used to control therapy delivered to the patient in a closed-loop manner. In addition, biomarkers may be used as an indication of therapy effectiveness.
